66
Sunny Pharmtech Inc.
6676.TWO · TWO
$11.20 -2.18% (-$0.25)
1M -8.76%
Market Cap $1.92B
P/E Ratio -
Div. Yield -
ROE 34.36%
Piotroski F-Score Weak
2/9Valuation
42 /100
Fair P/S 7.58x
P/B 2.54x
P/E N/A
Growth
0 /100
Declining Rev. growth 11.06%
Book val. growth 7.99%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 9.24%
Net margin 119.38%
Op. margin 125.50%
Quality
2 /100
Poor ROIC 24.45%
ROE 34.36%
ROA 21.53%
Debt
41 /100
Moderate Debt/Equity 0.64x
Current ratio 0.91x
Int. coverage -30.65x
Stability
16 /100
Unstable Beta 0.29x
Rev. volatility 29.69%
EPS volatility 106.48%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na 6676.TWO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Yon-Lian Wu
Employees
160
Headquarters
Taoyuan